Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Suvodirsen - Wave Life Sciences

Next Previous
X
Search
Drug Profile

Suvodirsen - Wave Life Sciences

Alternative Names: BMTR-0139; Exon 51 modulators - Wave Life Sciences; Suvodirsen sodium; Suvodirsen sodium - Wave Life Sciences; WLS-4176; WV-3473; WVE-210201

Latest Information Update: 02 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator WaVe life Sciences
  • Class Antisense oligonucleotides
  • Mechanism of Action Dystrophin expression modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Duchenne muscular dystrophy
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Duchenne muscular dystrophy

Most Recent Events

  • 19 Dec 2019 Wave Life Sciences terminates the phase I OLE trial in Duchenne muscular dystrophy in US, Belgium, Canada, France, Italy, the Netherlands and the United Kingdom (NCT03508947)
  • 19 Dec 2019 Wave Life Sciences terminates the phase II/III DYSTANCE 51 trial in Duchenne muscular dystrophy in US, Canada, Italy and Sweden (NCT03907072)
  • 17 Dec 2019 Discontinued - Phase-I for Duchenne muscular dystrophy (In adolescents, In children) in United Kingdom (IV), Netherlands (IV), Belgium (IV), Canada (IV), Italy (IV), France (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top